Hvad er CVR-nummeret på Hemab ApS?

Hemab ApS er registreret hos CVR / Virk under CVR 40837590.

Hvor mange medarbejdere har Hemab ApS?

Hemab ApS beskæftiger 42 personer pr. seneste årsrapport.

Benny Sørensen er administrerende direktør i Hemab ApS og har haft rollen siden 2022.

John Michael Maraganore er bestyrelsesformand i Hemab ApS og har haft rollen siden 2022.

Hemab ApSs registrerede adresse er Nordre Fasanvej 215.

APSActive

CVR 40837590Nordre Fasanvej 215, 2000 FrederiksbergFremstilling af farmaceutiske præparater· NACE 2120Stiftet 2019 · 6 år gammel42 ansatte

Nuværende ledelse

Name	Role	Member since
Current (2)
BS Benny Sørensen Chief Executive Officer	Chief Executive Officer	2022
MN Mads Nikolaj Behrndt-Eriksen Management	Management	2021

Tidligere (1)


JH Johan Henrik Faber Management	Management	2019 – 2023

Bestyrelsestilsyn

Name	Role	Member since
Current (4)
LC Linda Catharina Bain Board of Directors	Board of Directors	2022
AK Akshay Krishnadas Vaishnaw Board of Directors	Board of Directors	2024
BS Benny Sørensen Board of Directors	Board of Directors	2023
JM John Michael Maraganore Chairman	Chairman	2022

Tidligere (12)


JH Johan Henrik Faber Board of Directors	Board of Directors	2019 – 2021
TD Thomas Dal Stenfeldt Batchelor Board of Directors	Board of Directors	2021 – 2023
KS Kim Stengaard Holmsted Chairman	Chairman	2019 – 2020
HH Hans Heugh Wandall Chairman	Chairman	2020 – 2020
UC Uya Chuluunbaatar Board of Directors	Board of Directors	2023 – 2026
JS Jørgen Søberg Petersen Chairman	Chairman	2020 – 2022
JA Joseph Anderson Board of Directors	Board of Directors	2025 – 2026
MS Mårten Steen Board of Directors	Board of Directors	2021 – 2025
DB Daniel Becker Board of Directors	Board of Directors	2023 – 2026
SE Søren Erik Bjørn Board of Directors	Board of Directors	2020 – 2020
CP Camilla Petrycer Hansen Board of Directors	Board of Directors	2020 – 2021
LA Laura Anne Tadvalkar Board of Directors	Board of Directors	2021 – 2026

Pr. seneste årsrapport

Shareholder	Type	Ownership	Votes	Since
Hemab Therapeutics Holdings, Inc.	Company	100%	100%	2026
RA Capital Nexus Fund II, L.P.	Individual	5–9.99%	5–9.99%	2023
SMALLCAP World Fund, Inc.	Company	5–9.99%	5–9.99%	2025
RA Capital Healthcare Fund, L.P.	Individual	10–14.99%	10–14.99%	2025
DEEP TRACK BIOTECHNOLOGY MASTER FUND, LTD.	Company	5–9.99%	5–9.99%	2025
Ebumab Holding ApS	Company	5–9.99%	5–9.99%	2023
HealthCap VIII L.P.	Individual	5–9.99%	5–9.99%	2025
Novo Holdings A/S	Company	15–19.99%	15–19.99%	2025
AVORO VENTURES FUND L.P.	Individual	5–9.99%	5–9.99%	2023
AI DEN-MAB LLC	Company	10–14.99%	10–14.99%	2025
GV1 Holding ApS	Company	5–9.99%	5–9.99%	2020
Sofinnova Crossover II S.L.P.	Individual	5–9.99%	5–9.99%	2025

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.